ÂÜÀòÂÒÂ×

Dr. Rheault has served as the Vice President, of R&D and Global Project Management since January 2019.

Dr. Rheault started her career as a medicinal chemist at GlaxoSmithKline, where she was the inventor of the now marketed drug Tafinlar®. She then moved on to global project leadership for early development projects, including portfolio and governance management, before transitioning into late-stage clinical development as a clinical program and strategic drug development leader at IQVIA where she helped pharmaceutical companies develop integrated commercial and R&D strategies. Dr. Rheault received a Ph.D. in organic chemistry from North Dakota State University.